Search

Displaying results 8081 - 8090 of 10000 in total
  1. Drug

    BNT-162A1

    go.drugbank.com/drugs/DB16402
    Investigational

    BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).

  2. Drug

    Imeglimin

    go.drugbank.com/drugs/DB12509
    Investigational

    Imeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.

    Categories: Drugs Used in Diabetes
  3. Drug

    Canfosfamide

    go.drugbank.com/drugs/DB04972
    Investigational

    Canfosfamide is an active agent in chemotherapy-resistant ovarian cancer.

  4. Drug

    Bevonium

    go.drugbank.com/drugs/DB13542
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders, Analgesics, Non-Narcotic
  5. Drug

    Insulin-like growth factor II

    go.drugbank.com/drugs/DB14472
    Investigational

    It is believed to be a major fetal growth factor in contrast to insulin-like growth factor I, which is a major growth factor in adults. … The insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood.

    Synonyms: RH-oligopeptide-8, RH-polypeptide-31
  6. Drug

    Cefbuperazone

    go.drugbank.com/drugs/DB13638
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  7. Drug

    Ceftezole

    go.drugbank.com/drugs/DB13821
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  8. Drug

    Cefatrizine

    go.drugbank.com/drugs/DB13266
    Investigational

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  9. Drug

    Indantadol

    go.drugbank.com/drugs/DB12664
    Investigational

    Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  10. Drug

    SIG-001

    go.drugbank.com/drugs/DB17826
    Investigational

    SIG-001 is a cultured human retinal pigment epithelial cell line (ARPE-19) genetically modified with a non-viral vector to express B domain deleted human factor VIII protein, encapsulated within two-layer